ELABELA, as a potential diagnostic biomarker of preeclampsia, regulates abnormally shallow placentation via APJ
Authors:
- 1 May 2019
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 316 (5) , E773-E781
Abstract
CONTEXT: Preeclampsia is a major cause of maternal mortality and morbidity worldwide. Although there has been great progress in the understanding of preeclampsia, the exact cause for the disease development is still unclear. Recently, it showed that genetic deletion of ELABELA (ELA, also known as apela) could induce preeclampsia-like symptoms in mouse. However, the role of ELA in the disease development of preeclampsia remains elusive. OBJECTIVE: Measure the changes of ELA levels in maternal serum, urine and placenta from preeclamptic pregnancy and healthy pregnancy and evaluate the correlation between ELA level and the occurrence of preeclampsia. Meantime, investigate the effect of ELA on the migration and proliferation of human trophoblast cells. RESULTS: ELA level is significantly decreased in late-onset preeclampsia pregnancies compare to normal pregnancy. The mRNA and protein expression of ELA and apelin receptor (APLNR, or APJ) in late-onset preeclampsia placental tissues are also decreased. Furthermore, our in vitro study showed that addition of ELA significantly increased the invasion ability and proliferation of trophoblast cells, which was inhibited by the APJ specific antagonist-ML221. CONCLUSION: Our study identified ELA is significantly decreased in late-onset preeclampsia and thus it might play an important role in the pathogenesis of late-onset preeclampsia.Keywords
Funding Information
- National Natural Science Foundation of China (NSFC) (31401207, 31701234)
- the Priority Academic Program Development of Jiangsu Higher Education Institutions
- Natural Science Foundation from Jiangsu Province (BK20160043, BK20151546, 15KJA180004, BK20171035)
- Jiangsu Distinguished Professor Founding
- Natural Science Foundation of the Jiangsu Higher Education Institutions (17KJB180006)
- the national key Research and Development Program of China (2018YFD0900602)
This publication has 38 references indexed in Scilit:
- Hydroxysteroid (17-β) Dehydrogenase 1 Is Dysregulated by Mir-210 and Mir-518c That Are Aberrantly Expressed in Preeclamptic PlacentasHypertension, 2012
- Evaluation of 7 Serum Biomarkers and Uterine Artery Doppler Ultrasound for First-Trimester Prediction of Preeclampsia: A Systematic ReviewObstetrical & Gynecological Survey, 2011
- Magnesium sulphate and other anticonvulsants for women with pre-eclampsiaCochrane Database of Systematic Reviews, 2010
- Late Onset Preeclampsia is not an Innocuous ConditionHypertension in Pregnancy, 2010
- A proteomic approach identifies early pregnancy biomarkers for preeclampsia: Novel linkages between a predisposition to preeclampsia and cardiovascular diseaseProteomics, 2009
- Indications for delivery and short-term neonatal outcomes in late preterm as compared with term birthsAmerican Journal of Obstetrics and Gynecology, 2009
- Novel Biomarkers for Predicting PreeclampsiaTrends in Cardiovascular Medicine, 2008
- Neonatal Mortality and Morbidity Rates in Late Preterm Births Compared With Births at TermObstetrics & Gynecology, 2008
- Circulating Angiogenic Factors and the Risk of PreeclampsiaNew England Journal of Medicine, 2004
- Maternal Deaths Associated with Hypertensive Disorders of Pregnancy: a opulation‐Based StudyHypertension in Pregnancy, 2004